[go: up one dir, main page]

AU3556295A - Medicament containing p-oxybenzoic acid derivative and fibrate - Google Patents

Medicament containing p-oxybenzoic acid derivative and fibrate

Info

Publication number
AU3556295A
AU3556295A AU35562/95A AU3556295A AU3556295A AU 3556295 A AU3556295 A AU 3556295A AU 35562/95 A AU35562/95 A AU 35562/95A AU 3556295 A AU3556295 A AU 3556295A AU 3556295 A AU3556295 A AU 3556295A
Authority
AU
Australia
Prior art keywords
fibrate
acid derivative
medicament containing
oxybenzoic acid
oxybenzoic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35562/95A
Inventor
Matthias Heil
Michael Schliack
Klaus Seibel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Deutschland GmbH
Original Assignee
Klinge Pharma GmbH and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klinge Pharma GmbH and Co filed Critical Klinge Pharma GmbH and Co
Publication of AU3556295A publication Critical patent/AU3556295A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU35562/95A 1994-04-26 1995-04-25 Medicament containing p-oxybenzoic acid derivative and fibrate Abandoned AU3556295A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4414538 1994-04-26
DE4414538A DE4414538A1 (en) 1994-04-26 1994-04-26 Preparations for the therapy of combined hyperlipidemia containing a p-oxybenzoic acid derivative and a fibrate
PCT/EP1995/001565 WO1995028919A1 (en) 1994-04-26 1995-04-25 MEDICAMENT CONTAINING p-OXYBENZOIC ACID DERIVATIVE AND FIBRATE

Publications (1)

Publication Number Publication Date
AU3556295A true AU3556295A (en) 1995-11-16

Family

ID=6516473

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35562/95A Abandoned AU3556295A (en) 1994-04-26 1995-04-25 Medicament containing p-oxybenzoic acid derivative and fibrate

Country Status (5)

Country Link
AU (1) AU3556295A (en)
DE (1) DE4414538A1 (en)
EE (1) EE9400266A (en)
WO (1) WO1995028919A1 (en)
ZA (1) ZA953416B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
IL156445A0 (en) 2001-01-26 2004-01-04 Schering Corp Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
SI1355644T1 (en) 2001-01-26 2006-10-31 Schering Corp The use of substituted azetidinone compounds for the treatment of sitosterolemia
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
DK1429756T3 (en) 2001-09-21 2007-03-19 Schering Corp Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US20040092499A1 (en) 2002-11-06 2004-05-13 Schering Corporation Methods and therapeutic combinations for the treatment of autoimmune disorders
FR2851734B1 (en) * 2003-02-28 2006-06-09 Galenix Innovations PROCESS FOR THE PRODUCTION OF A PHARMACEUTICAL COMPOSITION IN THE FORM OF TABLETS CONTAINING A FIBRATE AND COMPRESSES OBTAINED BY THE PROCESS
WO2004081002A1 (en) 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
ATE418551T1 (en) 2003-03-07 2009-01-15 Schering Corp SUBSTITUTED AZETIDINONE DERIVATIVES, THEIR PHARMACEUTICAL FORMULATIONS AND THEIR USE IN THE TREATMENT OF HYPERCHOLESTEROLEMIA
CN1756755A (en) 2003-03-07 2006-04-05 先灵公司 Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326164A1 (en) * 1983-07-20 1985-01-31 Klinge Pharma GmbH, 8000 München NEW P-OXIBENZOESAEE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS

Also Published As

Publication number Publication date
DE4414538A1 (en) 1995-11-02
WO1995028919A1 (en) 1995-11-02
EE9400266A (en) 1996-02-15
ZA953416B (en) 1996-01-11

Similar Documents

Publication Publication Date Title
AU687936B2 (en) Medical clip
AU3532195A (en) Medicaments
AU2358895A (en) Medical electrode and method
AU6602196A (en) Electrode catheter
AU2505795A (en) 1-arylpyrimidine derivatives and pharmaceutical use thereof
AU2349295A (en) Low drag syringe and cartridge
AU3661695A (en) Pharmaceutical carriers
AU2473195A (en) Single use syringes
AU2474195A (en) Catheter apparatus
EP0690494A3 (en) Connection and build-up-process for multi-chip-modules
AU2630295A (en) 2-acylaminopropanol compound and medical composition
AU2860195A (en) Shield integrity monitor
AU4267396A (en) Modified cannula
AU3556295A (en) Medicament containing p-oxybenzoic acid derivative and fibrate
AU2523795A (en) Inhaler
AU2748895A (en) Medical nebuliser
AU691677B2 (en) Tetrahydroisoquinoline derivative and medicinal preparation containing the same
AU4344996A (en) Vessel-puncturing cannula
AU2512495A (en) Therapeutic phenoxyalkylazoles and phenoxyalkylazines
AU3913895A (en) Sterilization cell
AU2154695A (en) Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof
AU3982695A (en) Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments
AU1724695A (en) Breathing monitor
AU2343395A (en) A medical electrode
AU7820794A (en) Catheter